The Metastatic Renal Cell Carcinoma (MaRCC) Registry provides prospective data on real-world treatment patterns and outcomes in patients with metastatic renal cell carcinoma (mRCC).
Patients with mRCC and no prior systemic therapy were enrolled at academic and community sites.